| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Beone Medicines AG's insiders have reduced their positions by a net 31,028 shares worth roughly $11.3M. In the past 30 days, 0 insiders bought and 1 sold.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 397.9K | $141.25M | - | |
| Dir | 161.6K | $57.35M | - | |
| Other | 99.6K | $35.37M | - | |
| Dir | 83.7K | $29.72M | - | |
| Dir | 73.2K | $25.97M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 13, 2025 | Chan Henry Lee49 | SVP, General Counsel | Sale+OE10b5-1 | 11,013 | $300.45 | $3,308,877.31 | - | +11.8% | +15.8% | |
| Aug 1, 2025 | Aaron Rosenberg | Chief Financial Officer | Sell | 1,190 | $290.47 | $345,659.30 | -100% | +3.1% | +5.7% | |
| Jul 30, 2025 | Chan Henry Lee49 | SVP, General Counsel | Sell | 920 | $304.60 | $280,232.74 | -100% | +5.6% | - | |
| Jul 30, 2025 | Lai Wang50 | Global Head of R& D | Sell10b5-1 | 4,300 | $302.65 | $1,301,375.41 | -100% | +5.6% | - | |
| Jul 18, 2025 | Lai Wang50 | Global Head of R& D | Sell10b5-1 | 700 | $300.00 | $210,000.00 | -100% | +8.0% | +7.8% | |
| Jul 9, 2025 | John Oyler58 | Chief Executive Officer | Sell10b5-1 | 27,802 | $253.38 | $7,044,590.88 | -100% | +33.6% | - | |
| Jun 24, 2025 | Xiaodong Wang58 | Director, Chair, Scientific Advisory Brd | Sell10b5-1 | 2,007 | $265.50 | $532,867.36 | -100% | +26.6% | +3.9% | |
| Jun 23, 2025 | Lai Wang50 | Global Head of R& D | Sell | 1,028 | $260.00 | $267,280.00 | -100% | +31.2% | +4.9% | |
| Jun 23, 2025 | Xiaobin Wu52 | President and COO | Sell | 1,363 | $260.00 | $354,380.00 | -100% | +31.2% | +4.9% | |
| Jun 23, 2025 | John Oyler58 | Chief Executive Officer | Sell | 3,174 | $261.61 | $830,359.87 | -100% | +31.2% | +4.9% |